Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Key facts
- Who runs it
- Qianfoshan Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 10 May 2025
- Expected to end
- 31 Jan 2029
- Type of study
- Observational, 3 groups
- Record updated
- 4 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis
- Meets the diagnostic criteria for fungal-sensitized asthma
Who cannot take part
- Human immunodeficiency virus infection
- Malignant tumor
- Blood system disease
- autoimmune system disease
- History of pulmonary tuberculosis
- Patients with a history of smoking or still smoking
- Invasive pulmonary fungal disease
- Contraindications electronic bronchoscopy
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Allergic bronchopulmonary aspergillosis
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
The 3 groups in the trial
- allergic bronchopulmonary aspergillosis
- fungal-sensitized asthma
- control group
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07040332, who can take part
- Record updated
- 4 July 2025